1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with pulmicort in 5 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (pulmicort) | Trials (pulmicort) | Recent Studies (post-2010) (pulmicort) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 4,995 | 1,638 | 1,785 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | pulmicort (IC50) |
|---|---|---|---|
| Glucocorticoid receptor | Homo sapiens (human) | 0.0026 | |
| Progesterone receptor | Homo sapiens (human) | 0.028 | |
| Glucocorticoid receptor | Rattus norvegicus (Norway rat) | 0.0029 | |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.0045 | |
| Mineralocorticoid receptor | Homo sapiens (human) | 0.014 | |
| Matrix metalloproteinase-9 | Homo sapiens (human) | 1.989 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 1.1725 | |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 0.0045 | |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.0045 | |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.0045 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karvonen, JI; Koskinen, MO; Metsä-Ketelä, TJ; Moilanen, EK; Nieminen, MM; Tuomisto, L; Vapaatalo, H | 1 |
| Andersson, P; Brange, C; Chignard, M; Le Còuedic, JP | 1 |
| Bickel, CA; Bochner, BS; Kaiser, J; Schleimer, RP | 1 |
| Bazan, NG; Lukiw, WJ; Martinez, J; Pelaez, RP | 1 |
| Boedker, M; Boetkjaer, A; Cui, JG; Lukiw, WJ; Zhao, Y | 1 |
1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and pulmicort
| Article | Year |
|---|---|
Inhaled budesonide fails to inhibit the PAF-induced increase in plasma leukotriene B4 in man.
Topics: Administration, Inhalation; Adult; Blood Platelets; Bronchodilator Agents; Budesonide; Catecholamines; Drug Synergism; Female; Histamine; Humans; Leukotriene B4; Male; Methacholine Chloride; Middle Aged; Platelet Activating Factor; Platelet Count; Pregnenediones; Reference Values; Thromboxane B2 | 1992 |
4 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and pulmicort
| Article | Year |
|---|---|
Use of steroidal antiinflammatory drug provides further evidence for a potential role of PAF-acether in bronchial anaphylaxis.
Topics: Anaphylaxis; Animals; Bronchi; Budesonide; Guinea Pigs; Immunoglobulin E; In Vitro Techniques; Platelet Activating Factor; Pregnenediones | 1986 |
The effects of the potent glucocorticoid budesonide on adhesion of eosinophils to human vascular endothelial cells and on endothelial expression of adhesion molecules.
Topics: Budesonide; Cell Adhesion; Cell Adhesion Molecules; E-Selectin; Endothelium, Vascular; Eosinophils; Humans; In Vitro Techniques; Intercellular Adhesion Molecule-1; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; Pregnenediones; Vascular Cell Adhesion Molecule-1 | 1993 |
Budesonide epimer R or dexamethasone selectively inhibit platelet-activating factor-induced or interleukin 1beta-induced DNA binding activity of cis-acting transcription factors and cyclooxygenase-2 gene expression in human epidermal keratinocytes.
Topics: Anti-Inflammatory Agents; Budesonide; Cells, Cultured; Cyclooxygenase 2; Dexamethasone; DNA-Binding Proteins; Drug Antagonism; Humans; Interleukin-1; Isoenzymes; Keratinocytes; Membrane Proteins; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Protein Binding; Transcription Factors; Transcriptional Activation | 1998 |
Synergism in the repression of COX-2- and TNFalpha-induction in platelet activating factor-stressed human neural cells.
Topics: Anti-Inflammatory Agents; Budesonide; Cell Survival; Cells, Cultured; Cyclic N-Oxides; Cyclooxygenase 2; Dihydropyridines; Dinoprostone; Drug Synergism; Encephalitis; Gene Expression; Humans; Neurons; Oxidative Stress; Platelet Activating Factor; Signal Transduction; Stress, Physiological; Transcriptional Activation; Tumor Necrosis Factor-alpha; Up-Regulation | 2007 |